AUSTIN, TX (Feb. 26, 2020) – ConsenSys Health, which recently spun off from Ethereum giant ConsenSys, announced today that Dr. David Koepsell, founder and CEO of EncrypGen, has joined as its general counsel and chief ethics and compliance officer.
Already considered the leading blockchain healthcare and health science company, ConsenSys Health plans to continue building products, services and joint ventures in a number of major areas, including genomics.
“The addition of Dr. Koepsell to the ConsenSys Health leadership team brings a level of credibility and expertise we believe will be material to our ability to fill our vision to become the dominant player at the intersection of health and blockchain technology,” said Heather Flannery, founder and CEO of ConsenSys Health.
EncrypGen, which is already operational, will continue to adopt users organically and to bring DNA owners together anonymously with data buyers to improve science and provide value to all who have done genetic tests and wish to earn money from their de-identified data.
“I’m very proud to join the accomplished team of blockchain and healthcare technology professionals at ConsenSys Health and look forward to creating new and innovative healthcare technology and genomics opportunities for both companies,” said Dr. Koepsell.
EncrypGen Board Member Dr. Stephen Hwa will serve as interim CEO while the company conducts a search for a new chief executive and continues to pursue funding for its consumer roll-out. Dr. Koepsell remains the primary shareholder of EncrypGen and will continue to serve on its board of directors.
About ConsenSys Health
ConsenSys Health is a spin-off from ConsenSys, one of the world’s largest blockchain companies, focused on solving the biggest problems in healthcare. We are part of an ecosystem of technology and industry partners seeking to drive positive, inclusive change in healthcare and the life sciences. For more information, please visit www.ConsenSysHealth.com.
EncrypGen makes next-generation software to aide in safely storing and sharing genomic data for research and science, and to allow users to manage their own data and sell it to researchers. For more information, please visit www.EncrypGen.com.